Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Taro Pharmaceutical Entered Into Definitive Merger Agreement With Sun Pharma; Sun Pharma To Acquire All Taro's Outstanding Ordinary Shares Of Taro For $43/Share

Author: Benzinga Newsdesk | January 17, 2024 05:32pm

Agreed Price of US$43.00 per Share to Deliver 48% Premium to Unaffected Price on May 25, 2023

Posted In: TARO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist